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Available online 13 August 2016Disturbances in circadian rhythms have been suggested as a possible cause of bipolar disorder (BD). Included in
this study were 31 mood episodes of 26 BD patients, and 18 controls. Circadian rhythms of BD were evaluated at
admission, at 2-week intervals during hospitalization, and at discharge. All participants wore wrist actigraphs
during the studies. Saliva and buccal cells were obtained at 8:00, 11:00, 15:00, 19:00, and 23:00 for two
consecutive days. Collected saliva and buccal cells were used for analysis of the cortisol and gene circadian
rhythm, respectively. Circadian rhythms had different phases during acute mood episodes of BD compared to
recovered states. In 23 acute manic episodes, circadian phases were ~7 hour advanced (equivalent to ~17 hour
delayed). Phases of 21 out of these 23 cases returned to normal by ~7 hour delay along with treatment, but
two out of 23 cases returned to normal by ~17 hour advance. In three cases of mixed manic episodes, the phases
were ~6–7 hour delayed. For ﬁve cases of depressive episodes, circadian rhythms phases were ~4–5 hour
delayed. After treatment, circadian phases resembled those of healthy controls. Circadian misalignment due to
circadian rhythm phase shifts might be a pathophysiological mechanism of BD.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Bipolar disorder (BD) is a common mental disorder characterized by
episodic mood symptoms of mania or depression. Episodic relapses of
BD are very common, and therefore BD is one of themajor leading causes
of disability around the world (Goldberg and Harrow, 2004). Numerous
etiologies for BD have been proposed, but there is no conclusive evidence.
Humans exhibit an orchestration of circadian rhythmicity with
respect to the light-dark cycle (Reppert and Weaver, 2002), involving
regulation of physiological processes such as the autonomic nervousnam Hospital, Korea University
l 136-705, South Korea.
. This is an open access article undersystem, hormone secretion, and sleep-wake cycles (Dijk and Czeisler,
1995). Circadian rhythms can be entrained by both photic and nonphotic
stimuli, however light plays the primary role in the entrainment of the
human circadian pacemaker to the environment (Lavie, 2001). The
hypothalamic suprachiasmatic nuclei (SCN) are a master clock for the
orchestration of circadian rhythmicity. The SCN synchronize peripheral
oscillators to ensure temporally coordinated physiology, while the
peripheral oscillators interact among themselves and communicate
back to the SCN (Schibler and Sassone-Corsi, 2002). The endogenous
circadian rhythmicity affects timing for sleep-wake cycles and biochem-
ical rhythms. The circadian regulation of the sleep-wake cycle is thought
to bemediated bymultisynaptic projections from the SCN to sleep-wake
centers of the brain (Deurveilher and Semba, 2005; Saper et al., 2005).
Biochemical rhythms such as cortisol concentrations are also thought
to be affected by endogenous circadian timing systems (Bremner et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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rhythmicity may result from predictive regulation of function rather
than being entirely reactive, for example, body temperature and plasma
cortisol increase prior to waking from sleep (Fuller et al., 2006).
Disruptions of circadian rhythms have long been proposed as
a fundamental cause of BD (Gonzalez, 2014). Some research has
suggested that the intrinsic circadian pacemaker of BD was shorter than
a close-to-24-hour period (Wehr et al., 1985). Other hypotheses empha-
sized phase shifts as the primary circadian rhythm disturbances in BD
(Salvatore et al., 2008;Wood et al., 2009). Another formulation suggested
that instability in the behaviors of BD patients were keys to disruption of
circadian rhythms (Lee et al., 2013). There aremany studies suggesting an
associationbetweenvariations in circadiangenes andBDaswell as specif-
ic clinical subphenotypes (Maciukiewicz et al., 2014). Both lithium and
valproic acid, used to treat BD, havebeen shown to inﬂuence the rhythmic
expression of circadian genes and the rhythmic properties of molecular
clocks, especially via inhibition of glycogen synthase kinase-3β
(GSK-3β) (Li et al., 2002). There are awide diversity of reported circadi-
an abnormalities and many unresolved questions.
First, are there characteristic sequential changes in circadian
rhythms related to the exacerbation of BD symptoms? So far, studies
about the disturbances of circadian rhythms related to BD have been
almost entirely cross-sectional (Nurnberger et al., 2000; Wood et al.,
2009). If we identify sequential changes of circadian rhythms with
the clinical transitions from severe mood states (such as mania or
depression or mixed states) to euthymic states, it will provide a deeper
understanding of circadian rhythms associated with BD.
Second, how should we interpret the variations of circadian rhythm
shifts within studies of BD (Nurnberger et al., 2000; Salvatore et al.,
2008)? As highlighted by the subphenotypes in genetic studies of
BD (Craddock and Sklar, 2009), we speculate that there could be
several subphenotypes correlated with distinctive changes of circadian
rhythms within BD.
Third, are there inconsistencies in disorders when measuring
circadian rhythm variables of different body systems at the same time,
so-called internal desynchronization? Most of the studies have been
analyses of independent variables such as hormonal, genetic, or physical
activity (Nurnberger et al., 2000; Salvatore et al., 2008). However, these
variables may differ in sensitivity to reﬂect aspects of human circadian
rhythm systems. If we compare several circadian rhythm variables of
different systems at the same time, it might distinguish dysregulation
of circadian coordination in these systems.
To clarify the questions mentioned above, we serially measured be-
havior and biochemical circadian rhythms in BD during hospitalization
from severe states at admission to euthymic states at discharge, and
compared them with those of healthy controls.
2. Materials & Methods
2.1. Participants
The patients with BD were recruited from inpatients at the Depart-
ment of Psychiatry, Korea University Anam Hospital, Seoul, Republic ofTable 1
Demographic data of study population.
Patients w
Number of subjects 26
Age (mean ± SD), years 30.42 ± 10
Sex (M/F), N 13/13
Bipolar type (I/II), N 23/3
Education (mean ± SD), years 13.85 ± 1.
Age of onset (mean ± SD), years 21.19 ± 7.
Total number of mood episodes (mean ± SD) 7.62 ± 5.8
Family loading of mood disorder, % 57.7
Total number of psychiatric hospitalizations (mean ± SD) 3.62 ± 2.4
N, number of subjects.Korea. Included in the study were 26manic episodes of 22 Bipolar I dis-
order (BD-I) patients (12 male and 10 female) who were hospitalized
from May 2012 to June 2014, 5 depressive episodes of 5 BD patients
(2 male and 3 female, 2 BD-I and 3 BD-II) who were hospitalized from
June 2014 to March 2015, and 18 healthy subjects (11 male and 7
female) were assessed from September 2012 to November 2012. The
ages of the participants [mean ± SD] were 30.42 ± 10.88 years for
patients and 23.00 ± 3.57 years for healthy controls. One BD patient
was observed in both manic and depressed episodes during different
hospitalizations. In sum, 31 mood episodes requiring hospitalization of
26 BD patients were analyzed. There were no signiﬁcant differences
with respect to characteristics including age and sex among groups
(Table 1).
Diagnoses were determined by two psychiatrists (H.-J.L and C.-H.C)
according to DSM-IV-TR criteria using the Korean version of theMini In-
ternational Neuropsychiatric Interview (Yoo et al., 2006). Patients with
BD who needed to be hospitalized because of the aggravation of mood
symptoms, were recruited for the study. Inclusion criteria of the partic-
ipants were: 1) Diagnosis of BD according to DSM-IV-TR criteria and 2)
Acute mood episode requiring hospitalization for intensive psychiatric
treatment. Patients or controls with intellectual disability, organic
brain injury, or other major psychiatric disorders were excluded from
the present study. All participants underwent screening to exclude
past or present major medical disorders such as cardiovascular disease,
metabolic disease (including diabetes mellitus), hormonal disease
(including thyroid disease), and cancer. Clinical symptoms were evalu-
ated with the Young Mania Rating Scale (YMRS) (Young et al., 1978),
the 17-item Hamilton Depression Rating Scale (HAMD) (Hamilton,
1980), and the Clinical Global Impression-Bipolar Version (CGI-BP)
(Spearing et al., 1997).
Through in-depth interviews by a psychiatrist (H.-J.L) with all
volunteers, we conﬁrmed that controls had no personal or familial
psychiatric history. All participants completed questionnaires re-
garding their sleep conditions to exclude controls who had irregular
or disturbed sleep/wake patterns. Controls were excluded if work-
ing night shifts or reporting sleep patterns suggestive of circadian
rhythm phase disorders. The mood disorder questionnaire (MDQ)
was used to assess subthreshold bipolarity (Hirschfeld et al.,
2000). Only those with MDQ scores b7 were included in the control
group.
Participants were informed about the purpose and procedures of the
study and all participants provided informed written consent prior to
enrollment after a full explanation and thorough understanding of this
study. The study protocol was approved by the Institutional Review
Board of Korea University Anam Hospital and was conducted in
accordance with the Declaration of Helsinki.
2.2. Protocol
Patients were hospitalized during treatment and wore Actiwatch-L
activity recorders on a non-dominant wrist (Philips Respironics, Bend,
OR, USA). The sleep habits of hospitalized subjects were controlled by
the regular ward routine, i.e., they went to bed at 22:00 h and wereith bipolar disorder Healthy controls P value
18 –
.88 23.00 ± 3.57 0.083
10/8 0.717
N/A –
95 14.39 ± 2.33 0.407
68 N/A –
7 0 –
0 –
3 0 –
Table 2
Circadian rhythms of physical activity in bipolar disorder patients with manic and depressive episodes and healthy controls.
Manic episodes, N = 26 Depressive episodes, N = 5 Healthy controls, N = 18 P value
Acute state Recovered state Acute state Recovered state
Period, h 23.92 ± 0.59 24.02 ± 0.44 24.16 ± 0.23 24.04 ± 0.24 24.02 ± 0.66 0.859
Robustness, % 22.83 ± 9.1 22.93 ± 7.89 23.07 ± 3.55 23.08 ± 1.74 23.08 ± 5.03 0.993
Mesor 247.57 ± 72.12 245.76 ± 89.72 242.28 ± 33.29 244.26 ± 38.51 246 ± 46.2 0.986
Amplitude 169.88 ± 62.75 168.62 ± 48.82 162.54 ± 15.84 165.96 ± 22.4 168.58 ± 71.09 0.974
Acrophase, h 14.99 ± 1.32 15.38 ± 1.12 16.22 ± 1.06 15.88 ± 0.96 15.33 ± 2.12 0.324
M10 onset time, hh:mma 11:12 ± 01:03 11:13 ± 01:01 11:15 ± 00:49 11:12 ± 01:01 11:13 ± 01:05 0.998
M10 activityb 24,726 ± 5431 24,661 ± 2798 23,027 ± 3133 24,131.4 ± 6393 24,692 ± 4527 0.708
L5 onset time, hh:mmc 02:13 ± 01:04 02:16 ± 01:03 02:15 ± 01:16 02:12 ± 00:44 02:14 ± 01:03 0.998
L5 activityd 1518 ± 280 1444 ± 416 1351 ± 309 1407.6 ± 385 1467.61 ± 267 0.511
Relative amplitudee 0.87 ± 0.1 0.89 ± 0.03 0.89 ± 0.02 0.89 ± 0.03 0.89 ± 0.03 0.765
Values are mean ± SD.
P values are for differences among three group means corrected for time effects (manic episodes versus depressive episodes versus healthy controls).
N, number of episodes in BD patients and number of subjects in healthy controls; h, hour; M10, period of the 10 most active hours; and L5, period of the 5 least active hours. 26 manic
episodes include 3 mixed manic episodes.
a The onset time of periods for the 10 most active hours.
b The levels of activity during the 10 most active hours.
c The onset time of periods for the 5 least active hours.
d The levels of activity during the 5 least active hours.
e The difference between “M10 activity” and “L5 activity” and calculated as follows: (“M10 activity”− “L5 activity”)/(“M10 activity” + “L5 activity”).
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routine, i.e., the lights were turned off from 22:00 h to 06:00 h and
turned on from 06:00 h to 22:00 h. All BD patients had free access to
natural daylight through the window during the day, and provided
saliva (≥1 mL) directly into Salivettes (Sarstedt AG & Co., Nümbrecht,
Germany). Buccal epithelial cells were collected and immediately
placed into RNAlater (Sigma-Aldrich, St. Louis,MO,USA). Sample collec-
tionwas begunwith the start of hospitalization and continued at 08:00,
11:00, 15:00, 19:00, and 23:00 for two consecutive days and then
repeated at 2-week intervals during hospitalization and then right
before discharge. The nighttime sample collections (at 23:00) were
performed by well-trained experimental staff without additional light
exposure, under light as dim as possible, but these collections did
require brief awakenings, and it is known that patients with acute
psychiatric illnesses usually have disturbed sleep.
Each control subject participated in the study for oneweek andwore
an Actiwatch-L. Controls lived near the hospital and were asked to
maintain same sleep-wake schedules as hospitalized BD patients.
Their sleep-wake times were checked by actigraphy data. Controls
entered the hospital for the last two days of their participation, and
the sampling was performed in the same conditions as with patients.
2.3. Measurement of Physical and Sleep-Wake Activity
Circadian rhythms of physical activity were analyzed using the
Actiwatch-L and Cosinor software (Circadian Rhythm Laboratory ofTable 3
Circadian rhythms of sleep-wake activity in bipolar disorder patients with manic and depressi
Manic episodes, N = 26
Course of hospitalization
Manic 2 weeks after 4 weeks after Recovered
Sleep oneset time, hh:mm 21:56 ± 1:11 21:58 ± 0:52 21:39 ± 0:20 21:49 ± 0
Final wake time, hh:mm 6:35 ± 0:54 6:44 ± 1:00 6:35 ± 1:15 7:36 ± 4:5
Total sleep period, hh:mm 9:07 ± 1:27 9:11 ± 1:48 9:04 ± 0:46 8:58 ± 1:3
Total sleep time, hh:mm 7:33 ± 1:30 7:30 ± 1:36 7:38 ± 1:09 7:35 ± 1:2
Sleep onset latency, m 18.15 ± 15.19 19.35 ± 21.20 11.33 ± 13.76 9.96 ± 13
Sleep efﬁciency, % 79.97 ± 10.31 80.44 ± 9.15 83.58 ± 8.93 83.75 ± 9
Wake-time after sleep onset , m 78.77 ± 51.27 64.75 ± 47.89 55.00 ± 32.94 54.73 ± 45
Values are mean ± SD.
P values are for differences among successive time points for each group of manic and depress
N, number of episodes; and m, minutes.
⁎ P b 0.05.
⁎⁎ P b 0.01.Boise State University, Boise, ID, USA). The software estimates the
phase of a circadian rhythm by determining its acrophase, which is
the time of the peak of the best-ﬁtting sine curve, as illustrated in
several ﬁgures. Non-parametric circadian rhythm analysis was also per-
formed as described previously (Rock et al., 2014). “M10” and “L5”were
denoted as intervals of the 10 most active hours and the 5 least active
hours, respectively. “M10 activity” and “L5 activity” were deﬁned as
the levels of Actiwatch-L activity during “M10” and “L5”, respectively.
“Relative amplitude” was calculated as follows: (“M10 activity”− “L5
activity”)/(“M10 activity” + “L5 activity”).
Circadian rhythms of sleep-wake activity were analyzed using the
Actiwatch-L and Philips Respironics Actiware software (Philips
Respironics, Bend, OR, USA). “Sleep onset time” and “ﬁnal wake time”
were estimated by the algorithms of the software. “Total sleep period”
was deﬁned as a length of time from “sleep onset time” to “ﬁnal wake
time”, and the total sleep period included “wake time” within sleep,
which was deﬁned as minutes of activity by the algorithm. “Total
sleep time” was deﬁned as “total sleep period,” subtracting “wake
time”. “Sleep onset latency” was deﬁned as a length of time from
“bedtime” to “sleep onset time”. “Sleep efﬁciency” was denoted as
percentage of “total sleep time”/“total sleep period”.
2.4. Measurement of Salivary Cortisol
Coat-A-Count Cortisol (Siemens Healthcare Diagnostics Inc., Los
Angeles, USA) was used for salivary cortisol assays. The analyticalve episodes.
Depressive episodes, N = 5 Healthy
controls,
N = 18
P value Course of hospitalization P value
Depressive 2 weeks after Recovered
:53 0.763 21:42 ± 0:21 22:42 ± 1:43 22:36 ± 1:00 0.264 23:09 ± 1:41
4 0.001⁎⁎ 7:43 ± 0:53 6:43 ± 0:48 7:08 ± 0:51 0.449 7:01 ± 0:53
4 0.862 11:17 ± 1:27 8:55 ± 2:20 9:03 ± 1:16 0.063 8:11 ± 0:47
4 0.450 8:31 ± 1:58 7:13 ± 1:25 7:08 ± 0:43 0.363 7:38 ± 0:49
.43 0.146 17.80± 13.86 7.00 ± 1.41 13.60 ± 10.36 0.767 6.72 ± 9.56
.51 0.048⁎ 74.78 ± 7.41 81.68 ± 5.48 81.85 ± 6.15 0.293 84.44 ± 7.48
.45 0.238 91.20± 58.70 83.50 ± 51.62 62.20 ± 33.95 0.525 41.11 ± 36.17
ive episodes.
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289J.-H. Moon et al. / EBioMedicine 11 (2016) 285–295sensitivity was 0.01 μg/dL. The intra-assay coefﬁcient of variation was
3% for samples of 0.19 ± 0.10 μg/dL and 4% for samples of 0.24 ±
0.02 μg/dL. The inter-assay coefﬁcient of variation was 12% for samples
of 1.85 ± 0.10 μg/dL and 14% for samples of 0.24 ± 0.02 μg/dL.2.5. Measurement of Circadian Gene Expression
To observe circadian rhythms of gene expression, we tested ﬁve
circadian clock genes (ARNTL, PER1, PER2, PER3, and NR1D1) extracted
from buccal epithelial cells, and observed more relevant circadian
rhythms of ARNTL and PER1 than in the other genes. The circadian
rhythms of ARNTL and PER1 were inverse in phase to each other, in
agreement with previous studies of circadian oscillation (Akashi et al.,
2010; Chung et al., 2014; Guo et al., 2006; Novakova et al., 2015; Son
et al., 2008). Accordingly, to obtain the most distinguishable circadian
rhythms, we investigated the relative gene expression of ARNTL and
PER1, as performed and validated in a previous study (Cho et al., 2016;
Guo et al., 2006). Brieﬂy put, circadian gene expression levels of PER1
and ARNTL were determined by RT-qPCR: then their ratios of PER1/
ARNTL at each sampling time were used to describe circadian rhythms.
Total RNA was isolated using RNeasy Micro Kit (Qiagen Inc., Valencia,
CA, USA) from buccal epithelial cells, and only RNA samples concentrat-
ed to N200 ng/μL were subjected to next step. The whole RNA sample
was reverse-transcribed using the Sensiscript Reverse Transcription
Kit (Qiagen). Then, cDNA was subjected to the Taqman PCR reaction
using an Applied Biosystems StepOnePlus Real-Time PCR Systems
(ThermoFisher Scientiﬁc, Foster City, CA, USA). The primers and Taqman
probes used in this experiment are as follows; PER1 (NM_002616):
forward 5′-CTCACACAGCTCCTCCTCAG-3′, reverse 5′-TTTGTGCTCT
TGCTGCTCTC-3′, probe 5′FAM-CGGCAAGGACTCAGCCCTGC-3′BHQ1;
ARNTL (NM_001030272): forward 5′-TGCCTCGTCGCAATTGG-3′, re-
verse 5′-ACCCTGATTTCCCCGTTCA-3′, probe 5’FAM-CGACTGCATTCTC
ATGTAGTTCCACAACCA-3′BHQ1.2.6. Sine Regression Analysis
Biochemical rhythms were ﬁtted with sine curves using SigmaPlot
software (Systat Software Inc., San Jose, CA, USA).2.7. Statistical Analysis
Collected data were summarized using mean ± SD and frequencies
for continuous variables and categorical variables, respectively. We
conducted Fisher's exact tests and Wilcoxon rank sum tests in order to
compare general characteristics of categorical and continuous variables
among groups, respectively. For the analyses of physical, sleep-wake
activity, cortisol and gene expression, we used marginal models with
unstructured variance-covariance to compare groups and times
accounting for within subject correlation. In addition, we also consid-
ered the within-episode correlations, since episodes are nested within
subjects in these models. Post-hoc tests were applied if needed using
Tukey-Kramer tests which were proper for repeated measures data.
All analyses were implemented by SAS version 9.4 for Windows (SAS
Institute Inc., Cary, NC, USA).Fig. 1. The shifting of acrophases of circadian rhythms in bipolar disorder patients. Note that
transitions of salivary cortisol circadian rhythms in bipolar patients compared to controls as
ARNTL expression circadian rhythms in bipolar patients compared to controls. The outer
Acrophases of circadian rhythms of bipolar patients were observed over the course of hospi
every two weeks into recovery states (at the end of hospitalization). The arrow presents th
recovery state of each patient. If the duration of hospitalization was no longer than 2 weeks,
solid circle at the time of the ﬁrst acute acrophase assessment and the head of the arrow point
there were sometimes intermediate and ﬁnal assessments, with acrophases illustrated as t
acrophase of circadian rhythms in manic episodes, green arrows indicate that of mixed episo
range of acrophases for the healthy controls. The radius of each arc was arbitrarily chosen to c
circadian rhythms.2.8. Role of the Funding Source
The funder of the study had no role in study design, data collection,
data analysis, data interpretation, or writing of the report. The corre-
sponding author had full access to all the data in the study and had
ﬁnal responsibility for the decision to submit for publication.
3. Results
3.1. Circadian Rhythms of Physical and Sleep-Wake Activity
Patients did not show signiﬁcant differences in any parameters
for physical activity when compared to healthy controls, neither in
recovered nor during acute mood exacerbations (Table 2).
Analyses of sleep parameters of manic episodes found signiﬁcant
changes over time in group means for ﬁnal wake time and sleep
efﬁciency (Table 3). The ﬁnal wake time was delayed about 1 h and
the sleep efﬁciency was increased about 4% during hospitalization
from admission to recovery. In contrast, analyses of depressive episodes
found no signiﬁcant differences over time for any sleep parameters.
3.2. Biochemical Circadian Rhythms
Changes in biochemical circadian rhythms from acute to recovery
states of BD were observed (Fig. 1). Biochemical circadian rhythms of
acute mood episodes commenced with different phases compared to
those of the recovered states.
Fig. 1 and Table 4 clearly show that the biochemical circadian
rhythms of acute manic and depressive episodes were different from
those of controls. Notably, the biochemical circadian rhythms in salivary
cortisol concentrations and PER1/ARNTL expression ratios had contrast-
ing initial phases during the acute mood episodes, but transitioned by
comparable phase shifts during recovery, almost entirely arriving with-
in the normal control ranges.
3.3. Healthy Controls
The biochemical circadian rhythms in control subjects are depicted
in Table 4 and Fig. 2.
3.4. Manic Episodes
Of 26manic episodes, 21 episodes showed similar phase shifts of the
biochemical circadian rhythms during hospitalization (Figs. 1 and 3).
Signiﬁcant differences of acrophase of cortisol circadian rhythms were
observed in acute manic states and after 2 weeks of hospitalization
when compared with recovered states (Table 4). Similarly, acrophases
of gene expression circadian rhythms also showed signiﬁcant differ-
ences between acute manic states and after 2 weeks of hospitalization
when compared with recovered states (Table 4). In sum, at admission,
most of themanic episodes showed about 7 hour advanced biochemical
circadian acrophases in acute states (equivalent to 17 hour delayed),
and recovered through delays (clockwise), returning to the normal
range of the control group. Moreover, a signiﬁcant increase in the
PER1/ARNTL circadian amplitude accompanying recovery from maniathe acrophase is the timing of the peak of the best-ﬁtting sine curve. (a) The acrophase
the circadian peaks shifted in timing. (b) The acrophase transitions of the relative PER1/
circular axis indicates the clock time of each acrophase assessment for each patient.
talization. Evaluation was performed at acute states (near start of hospitalization), and
e direction of change in acrophase of the circadian rhythm from the acute state to the
there were only initial and ﬁnal assessments, so the acrophase arc is an arrow that has a
ing to the recovery acrophase. If the duration of hospitalization was longer than 2 weeks,
wo or three arrow heads along the arc. Red and orange arrows indicate the shifting of
des, and blue arrows indicate that of depressive episodes. The gray sector indicates the
ontrast the different groups of participants, and does not represent the amplitudes of the
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290 J.-H. Moon et al. / EBioMedicine 11 (2016) 285–295was observed in these manic episodes (Table 4). Circadian rhythms
of each patient recovering from the majority of manic episodes are
illustrated in the Supplemental Figs. S1 and S2 for cortisol and gene
expression, respectively.
However, two out of 26 manic episodes had a pattern of circadian
phase shifts different from those of the majority during recovery (Figs.
1 and 4). The admission biochemical circadian rhythms in the minority
manic states of the two cases were similar to the majority of manic
episodes (about 7 hour advanced as compared to recovered states),
but the recovery directions of the minor two cases were counterclock-
wise advances, opposite to those of majority. In other words, two
cases out of 26 manic episodes showed recovery shifting of about
17 hour advancing. Circadian rhythms of each subject in the minority
two cases of manic episodes are detailed in Supplemental Figs. S3 and
S4 for cortisol and gene expression, respectively.
3.5. Mixed Manic Episodes
Three out of 26 manic episodes were in mixed episodes displaying
manic symptoms and moderate depressive symptoms simultaneously.
These three mixed manic episodes showed a pattern of circadian
phase shifts different from those of other manic episodes during hospi-
talization (Figs. 1 and 5). Signiﬁcant differences of cortisol and gene
expression circadian rhythms were seen in the acute mixed states
when compared with those of recovered states (Table 4). In sum, pa-
tients in mixed states recovered from manic episodes by about 6–7 h
phase advances (counterclockwise). Circadian rhythms of each subject
in the mixed manic episodes are in Supplemental Figs. S5 and S6 for
cortisol and gene expression, respectively.
3.6. Depressive Episodes
Patients with depressive episodes showed about 4–5 hour delayed
biochemical circadian acrophases at the start of hospitalization, and
then recovered through advances to the normal ranges of the control
group (Figs. 1 and 6). Signiﬁcant differences of cortisol and gene expres-
sion circadian rhythms were seen in the acute depressive states when
compared with those of recovered states (Table 4). Circadian rhythms
of each subject with depressive episodes are detailed in Supplemental
Figs. S7 and S8 for cortisol and gene expression, respectively.
3.7. Clinical Symptoms
Clinical symptoms of patients with BD had been reduced during
treatment in all groups (Supplemental Figs. S9 and Table S1).
4. Discussion
This study suggests that acutemood episodes are related to circadian
misalignment between the individual's endogenous circadian rhythms
and the individual's physical environment. Acute manic episodes were
usually associated with biochemical circadian rhythm acrophases
averaging 7 hour more advanced (earlier) than those of controls,
though these acrophases could perhaps have resulted from an average
of 17 hour clockwise delays. Mixed manias were N6 hour delayed,
whereas bipolar depression was associated with 4–5 hour phase delays
compared to the controls. Interestingly, ﬁndings of advanced phase in
mania and delayed phase in depression are parallel to studies of jetlag
effects on BD that traveling east precipitate manic episode while
traveling west induces depressive episode (Inder et al., 2016).
Previous studies suggested that disturbance of circadian rhythms is a
possible mechanism of BD (Duarte Faria et al., 2015; Gonzalez, 2014;
Kripke et al., 2015; McClung, 2007; Wirz-Justice, 2006). However,
there has been no monitoring of circadian rhythms at the biochemical
level tracking the healing from an acute mood episode to euthymia.
291J.-H. Moon et al. / EBioMedicine 11 (2016) 285–295This study provides novel observations of resolution of circadian phase
abnormalities accompanying resolution of mood disturbances.
When biochemical circadian rhythms were observed in manic
episodes, most (21 of 26) episodes showed one pattern of phase shift.
Two cases of manic episodes showed similar acrophases in acute states
but different recovery directions to those of the majority of manic
episodes. Our data do not disclose the direction of phase shifting during
the development of mania, though some phase aberrations resolved in
opposite directions during recovery. Because these two different
recovery directions could be related tomedication effects, we compared
the medications between groups. However, there were no evident
differences in medication between the minority and majority of manic
episodes (Supplemental Table S2).
Three of 26manic episodes arose in mixed states and showed a pat-
tern of circadian shifts distinct from other manic episodes. During the
acute mixed states, patients showed about 6–7 hour delayed phases
compared to those in recovered states. Interestingly, when biochemical
circadian rhythms were observed in depressive episodes, the result
showed about 4–5 h delayed circadian phases in acute depressive states
compared to recovered states. Thus, the phase orientation of the
biochemical rhythms of the mixed manic-depressives during the acute
episodes were intermediate between the phases of pure manic and
the depressive episodes, seemingly corresponding to the intermediate
phenotype of mixed mania and depression. Both mixed manics and
depressives corrected the phase delay during the acute mood episode
by phase advance during recovery.
Mixedmania, also known as dysphoric mania or mixed features, is a
condition during which features of mania and depression occur almost
simultaneously. However, the pathophysiology of mixed mania was
not well established. Transitions between manic or depressive states
are common as demonstrated in a longitudinal study (Kotin and
Goodwin, 1972). Polyphasic episodes, in which state changes occur
without a euthymic mood period, resemble mixed states (Turvey et
al., 1999). Furthermore, Sit et al. reported that the mixed states were
induced by morning bright light treatment in women with bipolar
depression and midday light therapy did not (Sit et al., 2007), whichFig. 2.Mean biochemical circadian rhythms in healthy controls (N = 18). (a) Circadian rhyth
expression levels in healthy controls. Black dots indicate mean ± SEM, curved black lines indi
acrophases of each circadian rhythm.suggest that abrupt phase shifts by lightmay be a cause of mixed states.
It is possible that morning light therapy for bipolar depressive patients
induce further circadian delays because morning times may lie in the
delay zone in the phase response curve for light during bipolar depres-
sion (Khalsa et al., 2003). Furthermore, hypersensitivity of circadian
rhythm shifts to bright light has been suggested to be a possible biolog-
ical marker for sub-threshold bipolarity and BD (Cho et al., 2016; Lewy
et al., 1985).
One of the interesting aspects of the ﬁndings in this study is the
dissociation between the large phase advances/delays observed in the
biochemical rhythms and the much more moderate changes in the
sleep/wake cycle. We believe that this discrepancy mainly derives
from the environmental/behavioral constraints placed on sleep/wake
behavior with hospitalization and medications. From initial stage of
hospitalization, behavioral problems, especially sleep problems, were
intensively treated. If the patients had not been treated, we assume
that perhaps the discrepancies would not appear so great. Like adjust-
ments for jet lags, after environmental circadian realignment, it takes
time to be adjusted in alignment of the endogenous circadian rhythm.
We suggested that BD patients tend to be easily circadian phase shifted
by the disturbance of sleep wake cycles and some disordered Zeitgeber
(e.g., inappropriate artiﬁcial light).We observed that delays of the circa-
dian rhythm of salivary cortisol to bright light exposure before bedtime
is related to subthreshold bipolarity (Cho et al., 2016).
From these ﬁndings, we suggest a new circadian rhythm shift model
of BD (Fig. 7). Our observations indicate that the biochemical circadian
phase orientations had distinct abnormalities in acute manic episodes
versus mixed episodes versus depressive episodes, and that some
phase disturbances resolved through advance and others through
delay to recover the normal phase orientation. However, since we
have no observations of the development of these abnormal states, we
cannot infer with certainty whether some developed through advance
or others through delay. It has been hypothesized that both bipolar
depression and mania result from a tendency towards phase delay,
but mania occurs when the delay is more extreme than in depression
and may perhaps exceed 12 h, leading to resolution by a 360 degreems of salivary cortisol in healthy controls. (b) Circadian rhythms of relative PER1/ARNTL
cate the ﬁtted sine curves of mean values, and broken red lines indicate the timing of the
Fig. 3. Mean biochemical circadian rhythms in manic episodes (majority, N = 21
episodes). (a) Circadian rhythms of salivary cortisol in manic episodes (majority). (b)
Circadian rhythms of relative PER1/ARNTL expression levels in manic episodes
(majority). Black dots indicate mean ± SEM, curved black lines indicate the ﬁtted sine
curves ofmean values, and broken red lines indicate acrophases of each circadian rhythms.
Fig. 4.Mean biochemical circadian rhythms inmanic episodes (minority, N=2 episodes).
(a) Circadian rhythms of salivary cortisol in manic episodes (minority). (b) Circadian
rhythms of relative PER1/ARNTL expression levels in manic episodes (minority). Black
dots indicate mean ± SEM, curved black lines indicate the ﬁtted sine curves of mean
values, and broken red lines indicate acrophases of each circadian rhythms.
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excursions of distinct cell groups within the SCN may be involved,
contributing to internal desynchronization of peripheral circadian
rhythms. Indeed, bifurcation of circadian secretion of melatonin sug-
gesting bifurcation of SCN circadian systems has been hypothesized
(Kripke et al., 2015; Novakova et al., 2015). In this regard, we have not
noted any suggestion of bifurcation of individual circadian rhythms
we have observed in bipolar patients, but it is possible that some
dysregulation resembling pacemaker bifurcation might be suggested
by dramatic phase abnormalities in cortisol and RNA expression
contrasted to no signiﬁcant phase changes in sleep and gross activity.
Despite sequential observation of biochemical circadian rhythm
shifts during hospitalization in BD patients, we are aware of several
limitations. First, the sample size in this study was relatively small.Fig. 5.Mean biochemical circadian rhythms in mixed manic episodes (N = 3 episodes).
(a) Circadian rhythms of salivary cortisol in mixed manic episodes. (b) Circadian
rhythms of relative PER1/ARNTL expression levels in mixed manic episodes. Black dots
indicate mean ± SEM, curved black lines indicate the ﬁtted sine curves of mean values,
and broken red lines indicate acrophases of each circadian rhythms.Considering the difﬁcult study design, there were rather consistent
results despite the small sample sizes. Second, this study observed tran-
sitions of biochemical circadian rhythms over two weeks intervals. We
cannot sure what really happened in the initial two weeks of acute
manic and depressive episodes. Some portion of manic patients showed
normalized circadian shifts in the twoweeks. To overcome of these lim-
itations, future studies would be desirable with daily observation in the
early stages of mood episodes, especially manic episodes.
In conclusion, biochemical circadian rhythms in manic episodes of
bipolar patients were signiﬁcantly advanced compared to controls.
Mixed manic episodes and depressive episodes were associated with
phase delays. After the treatment, the shifted rhythm recovered to
normal. These ﬁndings provide a means for our understanding of theFig. 6.Mean biochemical circadian rhythms in depressive episodes (N = 5 episodes). (a)
Circadian rhythms of salivary cortisol in depressive episodes. (b) Circadian rhythms of
relative PER1/ARNTL expression levels in depressive episodes. Black dots indicate
mean ± SEM, curved black lines indicate the ﬁtted sine curves of mean values, and
broken red lines indicate acrophases of each circadian rhythms.
Fig. 7. Hypothesis on circadian rhythm shift model of bipolar disorder. Circadian phase orientations had distinct abnormalities in acute manic episodes versus mixed episodes versus
depressive episodes. The phase disturbances resolved through advance or delay to recover the normal phase orientation after treatment.
294 J.-H. Moon et al. / EBioMedicine 11 (2016) 285–295mechanisms of the circadian rhythmof bipolarmood episodes. The pos-
sibility of using circadian rhythms as a novel biomarker for diagnosis
and treatment monitoring in bipolar disorder is suggested by these
observations.
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